Release Therapeutics is a preclinical-stage BioMedTech company developing the first cell macroencapsulation technology designed to deliver potent therapeutic proteins beyond the human blood-brain barrier.
Company Details
- Employees
- 5
- Founded
- 2005
- Address
- Avenue De Sécheron 15, Genève,genève 1202,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- maxivax.ch
- Keywords
- to help accelerate our mission..
- HQ
- Genève, Genève
Release Therapeutics Questions
Release Therapeutics's website is maxivax.ch
Release Therapeutics's LinkedIn profile is https://ch.linkedin.com/company/releasetx
Release Therapeutics has
5 employees.
View email and phone details for 5
employees at Release Therapeutics.
Release Therapeutics's industry is
Biotechnology Research
Release Therapeutics's top competitors are
Nob Hill Therapeutics,
Crosspoint Therapeutics,
Ambrosia Biosciences Inc.,
Talus Bio,
Pittan,
Diakonos Oncology,
Nygen Analytics,
Borealis Biosciences, Inc.,
Biomatter,
Kinoxis Therapeutics Pty Ltd.
Release Therapeutics's categories are Biotechnology Research
Release Therapeutics's founding year is 2005
